<Anchor>



Yesterday (25th), while the number of new confirmed cases of COVID-19 was 1,200 and the vaccination completion rate was 70.9%, the first batch of Moderna vaccines commissioned by Samsung Biologics will be supplied to Korea this week. It looks like it will help to secure booster shots, that is, booster doses.



Reporter Choi Ho-won on the sidewalk.



<Reporter>



The domestically produced Moderna vaccine to be introduced this week is 2,435,000 doses.



The Ministry of Food and Drug Safety (MFDS) approved emergency use yesterday for the entire first batch of Samsung Biologics.



It has been more than five months since the Korea-U.S. summit in May and the consignment production contract was signed.



[Geun-hyeok Ryu / Vice Minister of Health and Welfare: This is the second case of inoculating Koreans with a COVID-19 vaccine produced by a domestic company after SK Bioscience's AstraZeneca vaccine.]



This quantity is part of the 40 million doses the government contracted with Moderna, It will be used for the 1st and 2nd inoculations and the 3rd booster inoculation in the 4th quarter.



The quarantine authorities expect that the quantity produced in the future will be supplied to Korea first.



[Jeong Eun-young / Director General of Vaccine Introduction of Central Accident Remediation Headquarters: If it is produced in Korea, we can quickly grasp the production and supply status, so it increases supply stability in that aspect... .]



Yesterday, 1,266 new confirmed cases remained relatively stable, but group infections continued.



At a nursing hospital in Daegu, two workers were confirmed on the 24th, and 39 more were confirmed.



As of 00:00 today, the completion rate of vaccination is 70.9%, and the government expects to achieve 80% by the end of next month.



However, to reach the mid-80%, it is necessary to persuade 10 million unvaccinated people to be vaccinated.



(Video Edit: Park Ji-in) 



▶ A dedicated area for those who have completed vaccination will be created…

"Review of the succession period"


▶ 'Vaccine pass' likely to be accepted for those with symptoms of thrombosis and paralysis